Showing results (971-980 of 5,142) with videos related to
Sort By:
Pageof 515
The Journal of Infection|September 27, 2020
Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infectionSeth R Shaffer, Julia Witt, Laura E Targownik, et al.The Journal of Infection|October 2, 2020
Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic reviewEva L Sudbury, Vanessa Clifford, Nicole L Messina, et al.The Journal of Infection|October 1, 2020
The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19Harun Kundi, Elif Hande Özcan Çetin, Uğur Canpolat, et al.The Journal of Infection|December 3, 2020
Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver testsBenjamin Patterson, Aula Abbara, Simon Collin, et al.The Journal of Infection|December 3, 2020
SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patientsRicardo Queiroz Gurgel, Laís Catarine de Sá, Daniela Raguer Valadão Souza, et al.The Journal of Infection|December 5, 2020
Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosisErnest Adankwah, Norman Nausch, Difery Minadzi, et al.The Journal of Infection|July 1, 1986
Anaerobic bacterial meningitisJ R Stephenson, P Hopper, S TabaqchaliThe Journal of Infection|September 1, 1985
Response to pneumococcal vaccination in normal and post-infected NigeriansG C Onyemelukwe, M Leinoen, H Makela, et al.The Journal of Infection|September 1, 1987
Risk of infection by Brucella melitensis for people living near infected goatsJ C Piffaretti, P Staedler, C F Beretta-PiccoliThe Journal of Infection|October 29, 2020
Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii: Acinetobacter baumannii therapeuticsPeter Gallagher, Stephen BakerPageof 515